KBEMS Pilot Programs- Adverse Event Notification

Similar documents
UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD REPORTING UNANTICIPATED PROBLEMS INCLUDING ADVERSE EVENTS

University of South Carolina. Unanticipated Problems and Adverse Events Guidelines

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

TITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18

Biomedical IRB MS #

I. Scope This policy defines unanticipated problems and adverse events and establishes the reporting process and timeline.

11/18/2016. UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities SESSION 4

PROMPTLY REPORTABLE EVENTS

ACRIN ADVERSE EVENT REPORTING MANUAL. 1 March 2006 v.3

POLICY ON RESEARCH RELATED ADVERSE EVENT REPORTING

DCP Safety Committee. Update and Review. January 19, 2017

Risk-Benefit Ratio and Determinations. Sarah Mumford, Ammon Pate, Annie Risenmay IRB Operations Managers University of Utah

Safety Reporting in Clinical Research Policy Final Version 4.0

The SOP applies to all human subject research falling under the purview of the University of Missouri Institutional Review Board.

Human Research Governance Review Policy

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

MEDICINES CONTROL COUNCIL

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

1. Department of Defense (DoD) Human Subjects Protection Regulatory Requirements

SOP Problems and Adverse Events, Record and Report

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky

Drugs and Cosmetics rules, 2013 India

SUNY Upstate Medical University GUIDELINES & POLICIES

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES

Various Views on Adverse Events: a collection of definitions.

COATS Coordinating Center Memo #3

Determining and Reporting Adverse Events vs. Product Complaints

FERCI MODEL SOPs. [The IEC members (author/s, reviewer/s) and Chairperson will sign and date the SOP on this first page]

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

University of Colorado Denver Human Research Protection Program Investigator Responsibilities for the Protection of Human Subjects

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

Version 4 January 18, Principal Investigator: James F. Marion, M.D. The Mount Sinai School of Medicine

Public Input for Changes to Reportable Events Policy

WHAT IS AN IRB? WHAT IS AN IRB? 3/25/2015. Presentation Outline

12.0 Investigator Responsibilities

Drugs and Cosmetics (First Amendment) Rules, 2013

MEDICINES CONTROL COUNCIL

Human Research Ethics Review Policy

STANDARD OPERATING PROCEDURE

RITAZAREM CRF Completion Guidelines

Adverse Event Reporting

ICH Topic E 2 D Post Approval Safety Data Management. Step 5 NOTE FOR GUIDANCE ON DEFINITIONS AND STANDARDS FOR EXPEDITED REPORTING (CPMP/ICH/3945/03)

Standard Operating Procedure

Roles of Investigators in the Managements of Clinical Trials

MEDICINES CONTROL COUNCIL

Version 1.1, 6/30/2016 Guidance for Abbreviated IDE Requirements

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

Title: Investigator Responsibilities. SOP Number: 1501 Effective Date: June 2, 2017

STANDARD OPERATING PROCEDURE SOP 205

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

PATIENT BILL OF RIGHTS & NOTICE OF PRIVACY PRACTICES

PATIENT INFORMATION. In Case of Emergency Notification

When a Single IRB Reviews for Multiple Sites:

Guidelines for Review of Research Involving Human Subjects

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

Genesis Health System. Institutional Review Board. Standard Operating Procedures

ADVANCED PLASTIC SURGERY, PLLC. NOTICE OF PRIVACY PRACTICES

APPLICATION FOR RESEARCH REQUESTING AN IRB WAIVER OF CONSENT AND HIPAA AUTHORIZATION

Issues of. Informed Consent. Mitchell E. Parrish, JD, RAC, CIP Regulatory Attorney

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Standard Operating Procedure (SOP) Research and Development Office

National Health Regulatory Authority Kingdom of Bahrain

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

Reporting to the IRB How to Report the Essentials and Improve the Protection of Human Subjects

BIMO SITE AUDIT CHECKLIST

Navigating Work Life Health. Affiliate Clinical Forms

Section 11. Adverse Event Reporting and Safety Monitoring

STATE OF FLORIDA DEPARTMENT OF. NO TALLAHASSEE, April 1, Safety INCIDENT REPORTING AND ANALYSIS SYSTEM (IRAS)

Notice of Privacy Practices for Protected Health Information (PHI)

WASHINGTON & JEFFERSON COLLEGE. Institutional Review Board (IRB) Policies and Guidelines

Home & Community Based Services Waiver Member Handbook

Grambling State University Application for Human Subjects Review IRB Protocol. 1. Principal Investigator [Last Name, First Name, Middle Initial]

Application Guide Global Awards in Transthyretin (TTR) Amyloidosis Research Research. A Competitive Grants Program Supported by Pfizer

Pediatric Dental Specialists

INDIANA STATE UNIVERSITY POLICIES AND PROCEDURES FOR THE REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS

Form B - For those enrolled in other insurance

Human Research Protection Program Institutional Review Board

PI Team: N/A. Medical Staff Officervices Printed copies are for reference only. Please refer to the electronic copy for the latest version.

Overview of Draft Pharmacovigilance Protocol

IRB Process for SURF April 21, 2015

Keele Clinical Trials Unit

Reference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015

Guide to Completing Medical University of South Carolina s Institutional Review Board (IRB) Continuing Review Application

Monitoring and Traceability Material Tracking Efficacy Monitoring Adverse Event Reporting

DO I NEED TO SUBMIT FOR THIS?... & OTHER FREQUENTLY ASKED QUESTIONS. March 2015 IRB Forum

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

IRB Federal Regulations Comparison Table 4/24/01 as updated through 10/31/01

SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board

CANADIAN UROLOGICAL ASSOCIATION SCHOLARSHIP FUND BLADDER CANCER CANADA RESEARCH GRANT. Terms of Reference Background

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION WITHOUT AUTHORIZATION

New European Union Clinical Trial Regulations

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

SOP Title: Reporting Adverse Events and New Safety Information

Ethics for Professionals Counselors

NOTICE OF PRIVACY PRACTICES MOUNT CARMEL HEALTH SYSTEM

Signature Date Date First Effective: Signature Date Revision Date:

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Request to Use an External IRB as an IRB of Record

Transcription:

KBEMS Pilot Programs- Adverse Event tification Emergencies and Reporting of Adverse Events The responsible project coordinator must promptly notify the Kentucky Board of EMS & the KCTCS HSRB of any problems involving human subjects that arise during the course of the Pilot Program. Problems include unanticipated side effects or adverse reactions from participation in the project and, of course, any injuries. If any emergency occurs during a Pilot Program, you should call 911 and be prepared to provide the following information to the dispatcher: 1) type of injury and what assistance is needed, 2) number of victims, 3) the location and instructions on how to get there, and 4) name and phone number. For research subjects at more than minimal risk, the consent form should include information on available medical treatment if injury should occur and whether any compensation is available for treatment of injuries. Immediate Cessation of Pilot Programs All unanticipated side effects and/or adverse reactions must be reported to the KBEMS and KCTCS HSRB. It will be the responsibility of the Pilot Program coordinator to immediately discontinue any Pilot Program in which an adverse effect or injury is associated. It will be within the purview of the Kentucky Board of EMS and the KCTCS HSRB to allow a program to continue after significant review of the details of the incident. KBEMS Pilot Project Program Adverse Event Report Page 1 of 7

For Unanticipated Problems, Serious or Life-Threatening Events, and related unanticipated Deaths Kentucky Board of Emergency Medical Services (KBEMS) and KCTCS Human Subjects Review Board (HSRB) The attached form is to be used ONLY for problems/adverse events occurring under KBEMS & KCTCS HSRB Purview and: All three criteria are true: OR #4 is true: OR #5 is true: 1. The problem/adverse event is serious/life-threatening or involving risks to subjects or others; 2. The problem/adverse event was an unanticipated incident; 3. The problem/adverse event is related * to the study procedures. 4. The problem/adverse event involves unanticipated or anticipated death which is related * to the study procedures. 5. The problem/adverse event does not fall under the KCTCS HSRB s prompt reporting requirements, but in the Pilot Program Coordinator s judgment, prompt reporting of the event(s) is in the best interest of the subject (s) because it may affect the safety and/or welfare of subjects and/or change the risk level of the study. Reporting Timeframe: All KBEMS approved Pilot Program problems/adverse events that are serious or life-threatening, AND unanticipated AND which are related * to the study procedures must be reported to KBEMS and the KCTCS HSRB using this form within the following timeframe: 1. Any unanticipated death of a subject occurring in a Pilot Program subject that is related* to the study procedures should be reported immediately (i.e. within 48 hours). The Pilot Program shall be discontinued immediately pending review by KBEMS and the KCTCS HSRB. 2. A problem/adverse event experienced by a subject that is life threatening and unanticipated, and related* to the study procedures, should be reported within 7 calendar days (1 week) of Pilot Program coordinator s receipt of information. 3. All other serious and unanticipated problems/adverse events that are related* to study procedures, must be reported within 14 calendar days (2 weeks) of investigator s receipt of information. KBEMS Pilot Project Program Adverse Event Report Page 2 of 7

Definitions: Unanticipated problem - any unforeseen or unexpected incident or experience (including an unanticipated adverse event) which is not described in the Pilot Program application or elsewhere in the current application. Unanticipated problem involving risk to subjects or others - any unforeseen or unexpected event or experience that adversely affects the rights, safety, or welfare of subjects or others (which is not described in the Pilot Program application). The event or experience could involve physical harm/risk (e.g., adverse event), social harm/risk (i.e., inappropriate breach in confidentiality, harm to a subject s reputation, or invasion of privacy), psychological harm/risk or legal harm/risk. The experience could also involve events not previously identified in severity or degree of incidence. An adverse event could be considered an unanticipated problem involving risk to subjects or others. Anticipated problem/adverse event any foreseen or expected incident/experience which was described in the Pilot Program application and approved by KBEMS and the KCTCS HSRB. Serious problem/adverse event - any incident that results in significant harm to or increased risk for the subject or others. Examples of events which are serious would include but are not limited to, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect. Important medical events that may not result in death, be lifethreatening, or require hospitalization may be considered a serious adverse event when, based upon appropriate medical judgment, they may jeopardize the subject s health or welfare and may require medical or surgical intervention to prevent one of the outcomes listed in this definition. Examples of such medical events include allergic bronchospasm requiring intensive treatment in an emergency room or at home, blood dyscrasias or convulsions that do not result in inpatient hospitalization, or the development of drug dependency or drug abuse. A disability is a substantial disruption of a person s ability to conduct normal life functions. Life-threatening event - any experience that places the subject, in the view of the Pilot Program Coordinator, at immediate risk of death from the reaction as it occurred, i.e., it does not include a reaction that, had it occurred in a more severe form, might have caused death. Related* - There is a reasonable possibility, in the opinion of the Pilot Program Coordinator, that the experience was more likely than not to have been caused by the research procedures. PPC- Abbreviation for Pilot Program Coordinator or Lead investigator. Complete all applicable items by entering information in the space provided. If items do not apply to your research, insert (t Applicable). Submit electronically and via hard copy to: KBEMS KBEMS Medical Advisor 300 rth Main Street Versailles, KY 40383 kbems@kctcs.edu AND KCTCS Human Subject Review Board Attn: Linda Morefield, 300 rth Main Street Versailles, KY 40383 linda.morefield@kctcs.edu KBEMS Pilot Project Program Adverse Event Report Page 3 of 7

For Unanticipated Problems, Serious or Life-Threatening Events, and Related Anticipated and Unanticipated Deaths IRB/IBC Check the applicable boxes: 1. The problem/adverse event is serious/life-threatening or involving risks to subjects or others; 2. The problem/adverse event was an unanticipated incident; 3. The problem/adverse event is related * to the study procedures. 4. 5. The problem/adverse event involves unanticipated or anticipated death which is related * to the study procedures. The problem/adverse event does not fall under the KCTCS HSRB s prompt reporting requirements, but in the Pilot Program Coordinator s judgment, prompt reporting of the event(s) is in the best interest of the subject (s) because it may affect the safety and/or welfare of subjects and/or change the risk level of the study. Pilot Program Coordinator Name: PPC Telephone Number: PPC E-mail Address: Title of Pilot Program: Name of Pilot Program Site/Organization: ADMINISTRATIVE INFORMATION Date this report completed: Type of report: Initial Follow-up Research Participant s study identification number/code: KBEMS Approval Number: HSRB Approval Number: Event Occurred at: Reports submitted to (check all that apply): KBEMS KCTCS HSRB FDA, if applicable Sponsor, if applicable Project is extramurally funded: Reporter name: Reporter Telephone number: Reporter E-mail address: Yes If yes, list agency(ies)/sponsor(s): KBEMS Pilot Project Program Adverse Event Report Page 4 of 7

KBEMS Protocol Number (if applicable): FDA IND Number (if applicable): FDA IDE Number (if applicable): KBEMS Pilot Program Adverse Event Reporting Form PROTOCOL AND PROBLEM / ADVERSE EVENT (AE) TYPE Unanticipated Anticipated and in PPC judgment requires prompt reporting Death _ Required intervention to prevent permanent Life-threatening impairment/damage Seriousness of the Initial or prolonged _ Emotional/Psychological Harm Problem/AE hospitalization _ Financial Harm (check all that apply): Disability _ Other medically important condition Congenital anomaly _ n-serious _ Other Severity of the Mild Moderate Severe Problem/AE Life-Threatening Fatal If death, date of death: / / Problem/AE Attributed to: Study medication Underlying disease Errors in study medication administration, or deviations Breach of Confidentiality Device Failure Social Science/Education Interventions _ Concomitant medication _ Medical Intervention Route of administration Invasion of Privacy _ Other suspected cause (describe on separate sheet) Research Subject Complaint (describe on separate sheet) Has the same Problem/AE occurred previously in this study? Yes If yes, how many times?: Research Participant s gender: M F Research Participant s Age in Years: Problem/AE Onset Date: / / SUBJECT DEMOGRAPHICS DETAILED UNANTICIPATED PROBLEM/ ADVERSE EVENT INFORMATION Problem/AE Termination Date: / / Event Continuing Description of Event (include time relationship to investigational procedures): Action taken in response to Problem/AE: KBEMS Pilot Project Program Adverse Event Report Page 5 of 7

If a subject death, was autopsy performed? Yes Date of autopsy: / / or Relevant tests (e.g. x-rays) and results: Describe treatment(s) of Problem/AE (Include medications used to treat this event.) List name of Concomitant Medications (Do not include medications used to treat this event.) Describe pre-existing conditions/relevant clinical history: Date(s) of treatment(s) of the Problem/AE: / / or _ the Problem/AE: Recovered/resolved Recovering/resolving Outcome of t recovered/not resolved Recovered/resolved with sequelae Fatal Unknown Other Was the administration of the test article stopped because of this Problem/AE? Documentation accompanying the report (e.g., H& P, Progress tes, Discharge Summary, Lab or Autopsy Reports, Other, etc.): Yes Description of any other documentation: SPECIFICATIONS FOR STUDY TEST ARTICLES, IF APPLICABLE Approved Drug Approved Device IND agent IDE agent What study test article was Placebo Blinded Study Agent administered/received? Other: Describe: Is this Problem/Event a result of a protocol deviation/exception/ violation? Yes (If the Problem/Event resulted from an HSRB-approved protocol deviation/exception, provide details on a separate sheet.) KBEMS Pilot Project Program Adverse Event Report Page 6 of 7

CONSENT/RISK/BENEFIT RATIO Problem/AE listed in Consent/Assent Form: Yes Approved Form Exempt Consent/Assent should be revised: Yes If yes, attach revised form with changes highlighted. Approved Form Presently enrolled subjects should be informed of Problem/AE: Yes Risk/Benefit Ratio has changed in light of Problem/AE: Yes Pilot Program Coordinator Signature: Date Program Medical Director Signature: Date For HSRB Committee Use Only Section I. (Check all that apply) This event does not involve risk to subjects or others because it is: not serious/life-threatening not related to the research Or, t unanticipated (i.e., the risk of this event is described in the Pilot Program application). Other (please explain): [te: If the event does not involve risk to subjects or others, the HSRB is determining the event does not suggest that the research places subjects or others at a greater risk of physical or psychological harm than was previously known or recognized and does not warrant consideration of substantive changes in the research protocol or informed consent process/document or other corrective actions in order to protect the safety, welfare, or rights of subjects. ~OHRP 1/15/07 Guidance on Reviewing and Reporting Unanticipated Problems Involving Risks to Subjects or Others and Adverse Events, III.C.] Section II. (Check one) Report Acknowledged/accepted without recommendation. Report Acknowledged/accepted pending receipt of additional information to be submitted to the HSRB. Comments: Committee Review Signature Date _ J:\Master Outreach Documents\Survival Handbook\F - IRB applications-forms\unanticipated Problems-Adverse Events\90000- Internal_Reporting_form_final.doc KBEMS Pilot Project Program Adverse Event Report Page 7 of 7